Next Article in Journal
Development of Co-Amorphous Systems for Inhalation Therapy—Part 1: From Model Prediction to Clinical Success
Next Article in Special Issue
Transdermal Drug Delivery Systems: Methods for Enhancing Skin Permeability and Their Evaluation
Previous Article in Journal
Synthesis and Evaluation of [18F]AlF-NOTA-iPD-L1 as a Potential Theranostic Pair for [177Lu]Lu-DOTA-iPD-L1
Previous Article in Special Issue
Formulation of Topical Drug Delivery Systems Containing a Fixed-Dose Isoniazid–Rifampicin Combination Using the Self-Emulsification Mechanism
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(7), 921; https://doi.org/10.3390/pharmaceutics17070921
Action Date Notes Link
article html file updated 22 July 2025 12:38 CEST Update https://www.mdpi.com/1999-4923/17/7/921/html
article pdf uploaded. 22 July 2025 12:35 CEST Updated version of record https://www.mdpi.com/1999-4923/17/7/921/pdf
article xml uploaded. 22 July 2025 12:35 CEST Update https://www.mdpi.com/1999-4923/17/7/921/xml
article xml file uploaded 22 July 2025 12:35 CEST Update -
article html file updated 18 July 2025 11:02 CEST Update -
article pdf uploaded. 18 July 2025 11:00 CEST Updated version of record https://www.mdpi.com/1999-4923/17/7/921/pdf-vor
article xml uploaded. 18 July 2025 11:00 CEST Update -
article xml file uploaded 18 July 2025 11:00 CEST Update -
article html file updated 17 July 2025 08:46 CEST Original file -
article pdf uploaded. 17 July 2025 08:44 CEST Updated version of record https://www.mdpi.com/1999-4923/17/7/921/pdf-vor
article xml uploaded. 17 July 2025 08:44 CEST Update -
article xml file uploaded 17 July 2025 08:44 CEST Original file -
article pdf uploaded. 16 July 2025 15:45 CEST Version of Record https://www.mdpi.com/1999-4923/17/7/921/pdf-vor
Back to TopTop